Elastrin Therapeutics is a UK and US-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.
| Website | http://www.elastrin.com |
| Employees | 5 (1 on RocketReach) |
| Founded | 2017 |
| Address | Robert Robinson Avenue, John Eccles House, Oxford, England OX4 4GP, GB |
| Phone | +1 864-656-3975 |
| Industry | Biotechnology Research |
| Keywords | Cardiovascular Disease, Biotechnology, Biotech, Disease Reversal, Heart Disease Treatment, Novel Therapies, Vascular Health, Drug Development, Therapeutic Solutions, Pharmaceutical Research, Innovative Treatments, Life Sciences, Pharmaceutical, Drug Discovery, Regenerative Medicine, Health Technology, Biomedical, Clinical Trials, Medical Innovation, Cell Therapy |
| Competitors | Novartis, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Vertex Pharmaceuticals, Lilly India +48 more (view full list) |
Looking for a particular Elastrin Therapeutics Inc. employee's phone or email?
Elastrin Therapeutics Inc. Questions
Mirko Stange is the Co-Founder and Now happy shareholder without operatational function of Elastrin Therapeutics Inc..
1 people are employed at Elastrin Therapeutics Inc..
Elastrin Therapeutics Inc. is based in Oxford, England.
Top Elastrin Therapeutics Inc. Employees
Related Companies
